{"transactions":[{"id":702039,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-07-28T20:15:15.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":47941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock of the Issuer. 19,976 shares vest upon grant and 3,995 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock of the Issuer. 19,976 shares vest upon grant and 3,995 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":47941,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":47941},"source":{"system":"sec-edgar","filing":"0001213900-26-082270","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000121390026082270/ownership.xml","form_type":"4/A","original_submission_date":"2026-05-18"}},{"id":737377,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T21:24:24.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":42100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents grant of restricted stock units (the \"Annual RSU Award\") payable solely in common stock of the Issuer. 17,542 shares vest upon grant and 3,508 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents grant of restricted stock units (the \"Annual RSU Award\") payable solely in common stock of the Issuer. 17,542 shares vest upon grant and 3,508 vest monthly over 7 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":126300,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":42100},"source":{"system":"sec-edgar","filing":"0001213900-26-068920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000121390026068920/ownership.xml","form_type":"4/A","original_submission_date":"2026-05-18"}},{"id":737376,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-15T21:24:24.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":84200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. 11,694 shares vest upon grant and 2,339 vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. 11,694 shares vest upon grant and 2,339 vest monthly over 31 months beginning June 1, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":84200,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":84200},"source":{"system":"sec-edgar","filing":"0001213900-26-068920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000121390026068920/ownership.xml","form_type":"4/A","original_submission_date":"2026-05-18"}},{"id":774283,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-19T00:57:35.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":42100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents grant of restricted stock units (the \"Annual RSU Award\") payable solely in common stock of the Issuer. The shares subject to the Annual RSU Award shall vest one year after date of grant, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents grant of restricted stock units (the \"Annual RSU Award\") payable solely in common stock of the Issuer. The shares subject to the Annual RSU Award shall vest one year after date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":126300,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":42100},"source":{"system":"sec-edgar","filing":"0001213900-26-058662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000121390026058662/ownership.xml","form_type":"4"}},{"id":774282,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-05-19T00:57:35.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":84200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":84200,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":84200},"source":{"system":"sec-edgar","filing":"0001213900-26-058662","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000121390026058662/ownership.xml","form_type":"4"}},{"id":940701,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-13T00:09:53.000Z","date":"2026-01-09","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":2.01,"expiration_date":"2036-01-09","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-26-002981","document":"tm262917-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465926002981/tm262917-7_4seq1.xml","form_type":"4"}},{"id":1041215,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on January 8, 2024 with the remainder vesting in substantially equal monthly tranches thereafter."}],"balance_after":30000,"derivative":{"exercise_price":12.68,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041214,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":false,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Stock option granted under the Instil Bio, Inc. 2021 Incentive Plan. 25% of the shares subject to the option vested on February 10, 2025 with the remainder vesting in substantially equal monthly tranches thereafter."}],"balance_after":17000,"derivative":{"exercise_price":11.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041213,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":12461,"price":23.88,"value":297568.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $23.71 to $24.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2)."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041212,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"sale","planned":false,"acquired":false,"shares":17539,"price":23.04,"value":404098.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $22.70 to $23.69, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":12461,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041211,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":13000,"price":12.68,"value":164840.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1041210,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Common Stock","published_at":"2025-09-12T21:00:55.000Z","date":"2025-09-10","kind":"exercise","planned":false,"acquired":true,"shares":17000,"price":11.6,"value":197200.0,"ownership":{"direct":true},"balance_after":17000,"source":{"system":"sec-edgar","filing":"0001789769-25-000087","document":"wk-form4_1757710851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000087/wk-form4_1757710851.xml","form_type":"4"}},{"id":1078891,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-07-30T20:30:17.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":21200,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41286,"derivative":{"exercise_price":4.71,"exercise_date":"2026-07-28","expiration_date":"2035-07-28","underlying":"Common Stock","underlying_shares":21200},"source":{"system":"sec-edgar","filing":"0001213900-25-069305","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000121390025069305/ownership.xml","form_type":"4"}},{"id":1164738,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-28T21:00:42.000Z","date":"2025-04-25","kind":"grant","planned":false,"acquired":true,"shares":44851,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on April 25, 2026, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":44851,"derivative":{"exercise_price":12.78,"expiration_date":"2035-04-24","underlying":"Common Stock","underlying_shares":44851},"source":{"system":"sec-edgar","filing":"0001789769-25-000041","document":"wk-form4_1745874035.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976925000041/wk-form4_1745874035.xml","form_type":"4"}},{"id":1400699,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-23T17:12:01.000Z","date":"2024-09-18","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on September 18, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":45000,"derivative":{"exercise_price":66.1,"expiration_date":"2034-09-17","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001789769-24-000095","document":"wk-form4_1727111515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976924000095/wk-form4_1727111515.xml","form_type":"4"}},{"id":1482881,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T23:01:37.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":1.44,"expiration_date":"2034-06-10","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-24-070517","document":"tm2416928-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465924070517/tm2416928-4_4seq1.xml","form_type":"4"}},{"id":1645267,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-13T22:40:12.000Z","date":"2024-02-10","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on February 10, 2025, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":80000,"derivative":{"exercise_price":11.6,"expiration_date":"2034-02-09","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001789769-24-000025","document":"wk-form4_1707863993.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976924000025/wk-form4_1707863993.xml","form_type":"4"}},{"id":1785517,"issuer":{"id":6568,"kind":"organization","name":"Unicycive Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-09-07T20:34:39.000Z","date":"2023-09-05","kind":"grant","planned":false,"acquired":true,"shares":189236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"63,079 options vest on June 26, 2024, 63,079 options vest on June 26, 2025 and 63,078 vest on June 26, 2026."}],"balance_after":200864,"derivative":{"exercise_price":0.76,"expiration_date":"2033-09-05","underlying":"Common Stock","underlying_shares":189236},"source":{"system":"sec-edgar","filing":"0001213900-23-075014","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000121390023075014/ownership.xml","form_type":"4"}},{"id":1842483,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-28T20:58:00.000Z","date":"2023-06-26","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":17.52,"expiration_date":"2033-06-26","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-23-075866","document":"tm2319786-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465923075866/tm2319786-5_4seq1.xml","form_type":"4"}},{"id":2049363,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:10:48.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":234000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":234000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":234000},"source":{"system":"sec-edgar","filing":"0001789769-23-000012","document":"wf-form4a_167424903416782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976923000012/wf-form4a_167424903416782.xml","form_type":"4/A","original_submission_date":"2022-03-07"}},{"id":2049362,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-01-20T21:08:03.000Z","date":"2023-01-08","kind":"grant","acquired":true,"shares":415000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":415000,"derivative":{"exercise_price":0.634,"expiration_date":"2033-01-07","underlying":"Common Stock","underlying_shares":415000},"source":{"system":"sec-edgar","filing":"0001789769-23-000008","document":"wf-form4_167424886036425.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976923000008/wf-form4_167424886036425.xml","form_type":"4"}},{"id":2259355,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T22:48:14.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":13.24,"expiration_date":"2032-05-19","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001104659-22-063970","document":"tm2216669-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465922063970/tm2216669-1_4seq1.xml","form_type":"4"}},{"id":2346965,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-03-07T22:06:40.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":234000,"price":8.62,"value":2017080.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to the option vest on March 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":234000,"derivative":{"exercise_price":8.62,"expiration_date":"2032-03-03","underlying":"Common Stock","underlying_shares":234000},"source":{"system":"sec-edgar","filing":"0001789769-22-000013","document":"wf-form4_164669078591142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976922000013/wf-form4_164669078591142.xml","form_type":"4"}},{"id":2667542,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-15T21:34:07.000Z","date":"2021-06-11","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":14500,"derivative":{"exercise_price":37.86,"expiration_date":"2031-06-11","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0001104659-21-081589","document":"tm2119762-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465921081589/tm2119762-4_4seq1.xml","form_type":"4"}},{"id":2713861,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T20:48:05.000Z","date":"2021-05-11","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on June 11, 2021, subject to the Reporting Person continuing to provide service through each such date."}],"balance_after":200000,"derivative":{"exercise_price":16.25,"expiration_date":"2031-05-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001789769-21-000032","document":"wf-form4_162093887102104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000178976921000032/wf-form4_162093887102104.xml","form_type":"4"}},{"id":2775909,"issuer":{"id":7177,"kind":"organization","name":"Instil Bio, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-03-23T00:53:17.000Z","date":"2021-03-18","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in forty-eight (48) equal monthly installments commencing on March 19, 2021, subject to the Reporting Person continuing to provide service through each such\ndate."}],"balance_after":240000,"derivative":{"exercise_price":5.95,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001209191-21-022474","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721664/000120919121022474/doc4.xml","form_type":"4"}},{"id":3086166,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-08T16:30:25.000Z","date":"2020-07-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 36 equal monthly installments beginning July 6, 2020."}],"balance_after":150000,"derivative":{"exercise_price":0.6216,"expiration_date":"2030-07-06","underlying":"Common stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001551986-20-000224","document":"wf-form4_159424021243087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198620000224/wf-form4_159424021243087.xml","form_type":"4"}},{"id":3090854,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-07-02T16:28:04.000Z","date":"2020-06-30","kind":"exercise","acquired":false,"shares":424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-04","underlying":"Common stock","underlying_shares":42400},"source":{"system":"sec-edgar","filing":"0001551986-20-000208","document":"wf-form4_159372161414654.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198620000208/wf-form4_159372161414654.xml","form_type":"4"}},{"id":3090853,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2020-07-02T16:28:04.000Z","date":"2020-06-30","kind":"exercise","acquired":true,"shares":42400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":60400,"source":{"system":"sec-edgar","filing":"0001551986-20-000208","document":"wf-form4_159372161414654.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198620000208/wf-form4_159372161414654.xml","form_type":"4"}},{"id":3134628,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-26T20:17:54.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full and become exercisable on the earlier of the first anniversary of the grant date or the day immediately prior to the date of the next BioXcel Therapeutics, Inc. annual meeting of stockholders, subject to the Reporting Person's continued service through such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":49.74,"expiration_date":"2030-05-21","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-065876","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465920065876/a4.xml","form_type":"4"}},{"id":3163349,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Warrant","published_at":"2020-05-04T18:47:40.000Z","date":"2020-05-04","kind":"purchase","acquired":true,"shares":424,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The purchase price of the warrant was included with the purchase price of the Series A Convertible Preferred Stock. The Series A Preferred Warrant is convertible into Series A Preferred Stock on a 1-for-1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The purchase price of the warrant was included with the purchase price of the Series A Convertible Preferred Stock. The Series A Preferred Warrant is convertible into Series A Preferred Stock on a 1-for-1 basis."}],"balance_after":42400,"derivative":{"exercise_date":"2020-05-04","expiration_date":"2025-05-04","underlying":"Common stock","underlying_shares":42400},"source":{"system":"sec-edgar","filing":"0001551986-20-000116","document":"wf-form4_158863244260467.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198620000116/wf-form4_158863244260467.xml","form_type":"4"}},{"id":3163348,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-05-04T18:47:40.000Z","date":"2020-05-04","kind":"purchase","acquired":true,"shares":424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The purchase price of the Series A Convertible Preferred Stock was $58.94 per share. The Series A Preferred Stock is convertible into Common Stock upon stockholder approval on a 1-for-100 basis, with no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The purchase price of the Series A Convertible Preferred Stock was $58.94 per share. The Series A Preferred Stock is convertible into Common Stock upon stockholder approval on a 1-for-100 basis, with no expiration date."}],"balance_after":42400,"derivative":{"exercise_date":"2020-05-04","underlying":"Common stock","underlying_shares":42400},"source":{"system":"sec-edgar","filing":"0001551986-20-000116","document":"wf-form4_158863244260467.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198620000116/wf-form4_158863244260467.xml","form_type":"4"}},{"id":3163347,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-04T18:02:40.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":389294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in full on 4/24/2020."}],"balance_after":389294,"derivative":{"exercise_price":0.6,"exercise_date":"2020-04-24","expiration_date":"2030-04-24","underlying":"Common stock","underlying_shares":389294},"source":{"system":"sec-edgar","filing":"0001551986-20-000108","document":"wf-form4_158862973478780.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198620000108/wf-form4_158862973478780.xml","form_type":"4"}},{"id":3427878,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Executive Chairman"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-27T18:41:07.000Z","date":"2019-08-20","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of these shares shall be deemed vested and exercisable on February 19, 2019 with the remainder vesting monthly over the next 48 months, subject to the executive's continuous service with the Company through each applicable vesting date."}],"balance_after":400000,"derivative":{"exercise_price":0.89,"expiration_date":"2029-02-18","underlying":"Common stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001551986-19-000107","document":"wf-form4_156694565180767.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198619000107/wf-form4_156694565180767.xml","form_type":"4"}},{"id":3474356,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Executive Chairman"}}],"security":"Common stock","published_at":"2019-07-01T17:00:03.000Z","date":"2019-06-28","kind":"purchase","acquired":true,"shares":4000,"price":1.15,"value":4600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.1477 to $1.1500, inclusive. The reporting person undertakes to provide to Innovate Biopharmaceuticals, Inc., any security holder of Innovate Biopharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001551986-19-000082","document":"wf-form4_156201478728094.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198619000082/wf-form4_156201478728094.xml","form_type":"4"}},{"id":3487303,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Executive Chairman"}}],"security":"Common stock","published_at":"2019-06-17T20:03:28.000Z","date":"2019-06-13","kind":"purchase","acquired":true,"shares":591,"price":1.22,"value":721.02,"ownership":{"direct":true},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001551986-19-000077","document":"wf-form4_156081619312014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198619000077/wf-form4_156081619312014.xml","form_type":"4"}},{"id":3487302,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Executive Chairman"}}],"security":"Common stock","published_at":"2019-06-17T20:03:28.000Z","date":"2019-06-13","kind":"purchase","acquired":true,"shares":409,"price":1.21,"value":494.89,"ownership":{"direct":true},"balance_after":13409,"source":{"system":"sec-edgar","filing":"0001551986-19-000077","document":"wf-form4_156081619312014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198619000077/wf-form4_156081619312014.xml","form_type":"4"}},{"id":3509755,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-29T01:01:03.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":14700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full and become exercisable on the first anniversary of the grant date."}],"balance_after":14700,"derivative":{"exercise_price":10.04,"expiration_date":"2029-05-23","underlying":"Common Stock","underlying_shares":14700},"source":{"system":"sec-edgar","filing":"0001104659-19-032143","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465919032143/a4.xml","form_type":"4"}},{"id":3513015,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, Executive Chairman"}}],"security":"Common stock","published_at":"2019-05-23T08:44:57.000Z","date":"2019-05-22","kind":"purchase","acquired":true,"shares":5000,"price":1.38,"value":6900.0,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001551986-19-000054","document":"wf-form4_155861548321435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198619000054/wf-form4_155861548321435.xml","form_type":"4"}},{"id":3745553,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-12-03T19:16:55.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":1000,"price":2.63,"value":2630.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001551986-18-000060","document":"wf-form4_154388259801782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000060/wf-form4_154388259801782.xml","form_type":"4"}},{"id":3745552,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-12-03T19:16:55.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":1000,"price":2.62,"value":2620.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001551986-18-000060","document":"wf-form4_154388259801782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000060/wf-form4_154388259801782.xml","form_type":"4"}},{"id":3745551,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-12-03T19:16:55.000Z","date":"2018-11-30","kind":"purchase","acquired":true,"shares":1000,"price":2.64,"value":2640.0,"ownership":{"direct":true},"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001551986-18-000060","document":"wf-form4_154388259801782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000060/wf-form4_154388259801782.xml","form_type":"4"}},{"id":3748622,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-11-29T18:13:25.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":2000,"price":2.56,"value":5120.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001551986-18-000055","document":"wf-form4_154353318919549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000055/wf-form4_154353318919549.xml","form_type":"4"}},{"id":3748621,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-11-29T18:13:25.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":1000,"price":2.55,"value":2550.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001551986-18-000055","document":"wf-form4_154353318919549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000055/wf-form4_154353318919549.xml","form_type":"4"}},{"id":3820347,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-09-10T17:49:20.000Z","date":"2018-09-07","kind":"purchase","acquired":true,"shares":500,"price":6.1,"value":3050.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Due to an administrative error, the holdings reported on Dr. Laumas's prior Form 4 filing were understated by 750 shares. This balance now reflects the correct amount of Dr. Laumas's direct holdings."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001551986-18-000029","document":"wf-form4_153661614405437.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000029/wf-form4_153661614405437.xml","form_type":"4"}},{"id":3829369,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-08-30T20:41:41.000Z","date":"2018-08-30","kind":"purchase","acquired":true,"shares":500,"price":5.24,"value":2620.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.24 to $5.25, inclusive. The reporting person undertakes to provide to Innovate Biopharmaceuticals, Inc. (the \"Issuer\"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":750,"source":{"system":"sec-edgar","filing":"0001551986-18-000027","document":"wf-form4_153567608554397.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000027/wf-form4_153567608554397.xml","form_type":"4"}},{"id":3829366,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-08-30T20:38:25.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":250,"price":4.9,"value":1225.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were inadvertently omitted from the original Form 4."}],"balance_after":250,"source":{"system":"sec-edgar","filing":"0001551986-18-000025","document":"wf-form4a_153567588887099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000025/wf-form4a_153567588887099.xml","form_type":"4/A","original_submission_date":"2018-08-28"}},{"id":3831303,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-08-28T18:17:58.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":405,"price":5.08,"value":2057.4,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001551986-18-000020","document":"wf-form4_153549465706467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/wf-form4_153549465706467.xml","form_type":"4"}},{"id":3831302,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-08-28T18:17:58.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":95,"price":5.07,"value":481.65,"ownership":{"direct":true},"balance_after":595,"source":{"system":"sec-edgar","filing":"0001551986-18-000020","document":"wf-form4_153549465706467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/wf-form4_153549465706467.xml","form_type":"4"}},{"id":3831301,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-08-28T18:17:58.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":250,"price":4.88,"value":1220.0,"ownership":{"direct":true},"balance_after":500,"source":{"system":"sec-edgar","filing":"0001551986-18-000020","document":"wf-form4_153549465706467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/wf-form4_153549465706467.xml","form_type":"4"}},{"id":3831300,"issuer":{"id":114271,"kind":"organization","name":"9 METERS BIOPHARMA, INC.","symbol":"NMTR"},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common stock","published_at":"2018-08-28T18:17:58.000Z","date":"2018-08-28","kind":"purchase","acquired":true,"shares":0,"price":4.9,"value":0.0,"ownership":{"direct":true},"balance_after":250,"source":{"system":"sec-edgar","filing":"0001551986-18-000020","document":"wf-form4_153549465706467.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198618000020/wf-form4_153549465706467.xml","form_type":"4"}},{"id":3997509,"issuer":{"id":8380,"kind":"organization","name":"BioXcel Therapeutics, Inc."},"owners":[{"id":28185,"kind":"person","name":"Laumas Sandeep","position":1,"cik":"0001721664","reported_name":"Laumas Sandeep","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2018-03-13T21:13:24.000Z","date":"2018-03-12","kind":"grant","acquired":true,"shares":37209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option vest as follows: one-third (12,403 shares) on each of 3/12/2019, 3/12/2020 and 3/12/2021."}],"balance_after":124188,"derivative":{"exercise_price":11,"expiration_date":"2028-03-12","underlying":"Common Stock","underlying_shares":37209},"source":{"system":"sec-edgar","filing":"0001104659-18-017151","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1720893/000110465918017151/a4.xml","form_type":"4"}}]}